Navigation Links
Early success of anti-HIV preventive oral drug regimen is promising, but questions remain
Date:3/14/2011

New Rochelle, NY, March 14, 2011The first human studies of an oral drug regimen to prevent HIV infection in high-risk individuals yielded a promising near 50% reduction in HIV incidence, but a number of issues require additional research before oral pre-exposure prophylaxis (PrEP) can be implemented on a large scale, according to an article in AIDS Patient Care and STDs, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The article is available free online at www.liebertpub.com/apc

After the success of a trial of PrEP in a high risk population of men who have sex with men (MSM), expanded studies are set to begin that will enroll more than 20,000 men and women. Although PrEP comprised of a two-drug regimen (the oral antiretroviral agents tenofovir and emtricitabine) was shown to be safe and effective in early clinical testing, Gavin Myers, MA and Kenneth Mayer, MD, Alpert Medical School of Brown University (Providence, RI) emphasize the need for more research in several key areas: the need for ongoing PrEP clinical monitoring of side effects; the diminished preventive benefits seen in patients who do not adhere to the PrEP regimen and the need for counseling; the attitudes and awareness of physicians who would be prescribing PrEP; and the potential for intermittent PrEP to be as effective as once-daily dosing. They discuss these issues in the article, "Oral Preexposure Anti-HIV Prophylaxis for High-Risk U.S. Populations: Current Considerations in Light of New Findings."

"This is an extraordinary example of translational medicine in the service of HIV prevention. But implementation faces major social obstacles. Adherence to a PreP regimen is key. And the cost of the drugs may make it impractical for all but the highest at-risk populations," says Jeffrey Laurence, MD, Editor-in-Chief of the Journal and Director of the
'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

0

GOOD

Page: 1 2

Related medicine news :

1. Simple blood test detects early emphysema in smokers before symptoms appear
2. CWRU researcher sends message to postmenopausal women: Increase yearly dental checkups
3. High-volume portable music players may impair ability to clearly discriminate sounds
4. JCI online early table of contents: March 7, 2011
5. Noninvasive Test May Identify Down Syndrome Early On
6. Early Rehab May Help Speed Recovery After Knee Surgery
7. Smoking During Early Pregnancy May Put Babys Heart at Risk
8. Spontaneous smoking cessation may be an early symptom of lung cancer, research suggests
9. K-State chemists work brings more national recognition as promising early-career scientist
10. Early Symptoms in Menopause Might Protect Heart
11. Bone drug zoledronic acid may help prevent spread of early lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Early success of anti-HIV preventive oral drug regimen is promising, but questions remain
(Date:5/24/2013)... Texas (PRWEB) May 24, 2013 This ... 2022” provides an overview of the risk factors and ... (8MM) (US, France, Germany, Italy, Spain, UK, Australia, and ... cases of meningococcal disease segmented by age (<1, 1–4, ... (B, C, Y, and W-135) in these markets. The ...
(Date:5/24/2013)... PA (PRWEB) May 24, 2013 Patients ... be more likely to suffer from gastroesophageal reflux disease ... physicians reported in a study published today. , The ... Abnormal Proximal Exposure as Measured by Hypopharyngeal Multichannel Intraluminal ... findings could be of great importance to individuals who ...
(Date:5/24/2013)... 24, 2013 Ten Seattle’s Best Coffee ... stores were fabricated and installed over the last 3 ... Palomar Modular Buildings . , “The custom specifications for ... They made a conscious decision to utilize the modular ... with the build quality they wanted, and their plan ...
(Date:5/24/2013)... have today released updated guidelines on Hormone Replacement Therapy ... the benefits and the risks. The new guidelines appear ... published by SAGE. , Over the last 11 ... of youth" to being considered extremely risky and only ... of the Women,s Health Initiative (WHI) trial in 2002, ...
(Date:5/24/2013)... 2013 http://www.resource4thepeople.com/defectivedrugs/Zithromax-lawsuits.html , ... update involving allegations that the use of the ... allegedly cause potentially fatal irregular heart rhythms. ... 17, 2013* that Health Canada has joined the ... Zithromax can cause abnormal changes in the electrical ...
Breaking Medicine News(10 mins):Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 2Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 3Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 4Health News:West Penn Allegheny Health System Physicians Pinpoint Gastroesophageal Reflux Disease (GERD) as a Factor That May Cause Chronic Cough 2Health News:Seattle’s Best Coffee Gets Modular 2Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 2Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 3Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 4
... growing challenge, researchers say , , FRIDAY, Aug. 1 (HealthDay ... in countries with high rates of multi-drug resistant (MDR) ... Health Organization data from 2003 to 2004 for ... MDR-TB, patients are nearly twice as likely to fail ...
... WASHINGTON, August 1 Mark Merritt, President,of ... following,statement in response to new comparative effectiveness ... Committee Chair Max Baucus,(D-Mont.) and Senate Budget ... applaud Senators Baucus and Conrad for helping ...
... SAN FRANCISCO, CA The August issue of Ophthalmology, ... includes surprising findings on Asian ethnicity and macular degeneration ... a study of successful treatments for ocular surface cancer. ... Population , AMD erodes and can eventually destroy the ...
... nutritional supplement renowned for enhancing athletic performance and ... patients with chronic obstructive pulmonary disease (COPD), according ... study provided the most powerful evidence to date ... negligible at best among these patients. , "We ...
... in the document scanning industry, announced that its ... http://www.imagedocusa.com . The site introduces a ... businesses to "Go Paperless!" ImageDoc USA, headquartered ... and has created a reputation as a niche ...
... in the August 2008 edition of Otolaryngology ... medical community to develop a national consensus on ethical ... casualties of disasters such as hurricanes, tornadoes, floods, or ... Academy of Otolaryngology-Head and Neck Surgery,s Ethics Committee Chair, ...
Cached Medicine News:Health News:Drug Resistance Is Slowing Global Fight Against TB 2Health News:Highlights from the August 2008 issue of Ophthalmology 2Health News:Highlights from the August 2008 issue of Ophthalmology 3Health News:Highlights from the August 2008 issue of Ophthalmology 4Health News:No substitute for hard work: Creatine supplementation does not improve exercise outcomes in COPD 2Health News:ImageDoc USA, Inc. Launches "Go Paperless!" Website 2
(Date:5/23/2013)... , May 23, 2013  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... been named the 2013 Life Science Firm of the Year ... (TCM).  Vanda was honored at the TCM,s 25 th ... , Maryland.  The Tech Awards Celebration recognizes the leaders and ... Maryland and the surrounding regions. ...
(Date:5/23/2013)... May 23, 2013 Nephros, Inc. (OTC Bulletin ... device company that develops and sells high performance liquid ... rights offering.  In addition, the concurrent temporary reduction in ... on May 17, 2013. Nephros estimates that ... the rights offering.   A portion of the proceeds will ...
(Date:5/23/2013)...  Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), ... on intellectual property developed and owned by Hadassah ... medical research center, today announced that its portfolio ... from the Israeli Ministry of Industry and Commerce, ... product development and advance clinical trials. Cell Cure,s ...
Breaking Medicine Technology:Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... DETROIT , March 11 Caraco ... launched oxaliplatin injections. These 50mg and 100mg oxaliplatin injections, ... approval from the US Food and Drug Administration (FDA) ... is an anticancer used in the treatment of colon ...
... today the commercial launch of its new VivoTag ® 680 XL fluorescent dye for labeling biomolecules in a broad range of ... ... ... ...
Cached Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 3VisEn Launches New VivoTag(R) 680 XL Fluorescence Molecular Imaging Label 2VisEn Launches New VivoTag(R) 680 XL Fluorescence Molecular Imaging Label 3VisEn Launches New VivoTag(R) 680 XL Fluorescence Molecular Imaging Label 4
Kleinert-Kutz Single Skin Hook, Large...
Medium....
Goldman single hook....
These products are supplied non-sterile and must be sterilized before use. For insertion through the smokevac and nezhat-dorsey trumpet valve in conjunction with the universal instrument insert adapt...
Medicine Products: